It should have more risks than we could see. The question about the risks are hard to get accurate answer, right?
The comparison between dog and dog is helpful but depending on what we want to compare. It is always need the special case study to think about the risks since the risk profile should be different to everyone.
We want to open mind but what the worst case to PRR in the historical and future prospective?
prima biomed back in the spotlight, page-26
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
0.008(2.21%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 33.5¢ | $1.943M | 5.556M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 183720 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 111469 | 28 |
View Market Depth
| Last trade - 15.43pm 18/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |